Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Arrhythmias

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 243 articles: HTML format

Single Articles

March 2026
1. VECCHIATO M, Neunhaeuserer D, Degano G, Battista F, et al
   The diagnostic value of including an exercise session during 24-h ambulatory ECG monitoring in athletes.
   Int J Cardiol. 2026;446:134098.
   PubMed     Abstract available
   
   
   February 2026
2. YANO M, Egami Y, Kise M, Mukai T, et al
   Inflammation and myocardial injury after pulmonary vein isolation with distinct pulsed field ablation modalities: Comparison with thermal ablation.
   Int J Cardiol. 2026;445:134047.
   PubMed     Abstract available
   
   
   
3. POLIZZI R, Canciello G, Ordine L, di Napoli S, et al
   Reverse septal curvature in hypertrophic cardiomyopathy: Implications for function, structure and arrhythmic risk.
   Int J Cardiol. 2026;444:134013.
   PubMed     Abstract available
   
   
   
4. BONANNI F, Gueli IA, Bellisario I, Todiere G, et al
   European task force reclassification of dilated and non-dilated cardiomyopathies identifies a high arrhythmic-risk overlap phenotype.
   Int J Cardiol. 2026;444:133999.
   PubMed     Abstract available
   
   
   January 2026
5. NIU Z, Wei Z, Wang J, Jin X, et al
   Analysis of the diagnostic value of pre-event intracardiac electrogram (pre-EGM) storage function in cardiac electronic implantable devices for arrhythmia diagnosis.
   Int J Cardiol. 2026;442:133881.
   PubMed     Abstract available
   
   
   December 2025
6. HINOJOSA W, Velazquez-Martin M, Coronel ML, Segura de la Cal T, et al
   Prognostic value of longitudinal QTc interval analysis in pulmonary arterial hypertension.
   Int J Cardiol. 2025;441:133816.
   PubMed     Abstract available
   
   
   
7. HOROWITZ H, Amsalem I, Carasso S, Postell YY, et al
   Atrial fibrillation and clinical outcomes after mitral transcatheter edge-to-edge repair: A mechanism-stratified cohort study.
   Int J Cardiol. 2025;446:134095.
   PubMed     Abstract available
   
   
   
8. MAYNTZ SP
   Left atrial appendage orifice area and risk of silent cerebral embolism after atrial fibrillation ablation.
   Int J Cardiol. 2025 Dec 9:134084. doi: 10.1016/j.ijcard.2025.134084.
   PubMed    
   
   
   November 2025
9. WANG FZ, Liu YS, Ma M, Wang RG, et al
   Histological analysis of the ligament of Marshall and its Secretome in patients with atrial fibrillation.
   Int J Cardiol. 2025 Nov 26:134064. doi: 10.1016/j.ijcard.2025.134064.
   PubMed     Abstract available
   
   
   
10. CHEN L, Du X, Liu J, Cui C, et al
    LAA orifice area assessed by CTA is associated with silent cerebral embolism in patients with atrial fibrillation catheter ablation.
    Int J Cardiol. 2025 Nov 19:134036. doi: 10.1016/j.ijcard.2025.134036.
    PubMed     Abstract available
    
    
    
11. GULLETTA S, Fioravanti F
    Editorial: The clock is ticking - Why time to ablation matters in atrial fibrillation?
    Int J Cardiol. 2025 Nov 18:134029. doi: 10.1016/j.ijcard.2025.134029.
    PubMed    
    
    
    
12. XU X, Liu Z, Liu Z, Li Z, et al
    Increased sympathetic outflow induced by ventromedial hypothalamic nucleus activation aggravates cardiac electrophysiology disturbance after myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2025;439:133634.
    PubMed     Abstract available
    
    
    
13. KUNAK AU, Kaplan M, Aciksari G, Mert KU, et al
    Knowledge and awareness of nonvalvular atrial fibrillation and anticoagulant therapy: Association with medication adherence in a cross-sectional survey.
    Int J Cardiol. 2025 Nov 10:134020. doi: 10.1016/j.ijcard.2025.134020.
    PubMed     Abstract available
    
    
    
14. ANAGNOSTOPOULOS I, Vrachatis D, Kousta M, Giotaki S, et al
    Early catheter ablation versus conservative- only management in patients with electrical storm. Systematic review and meta- analysis.
    Int J Cardiol. 2025;438:133597.
    PubMed     Abstract available
    
    
    October 2025
15. YAFASOVA A, Doi SN, Thune JJ, Nielsen JC, et al
    Effect of implantable cardioverter-defibrillator in non-ischemic heart failure according to heart failure etiology: Extended follow-up of the DANISH trial.
    Int J Cardiol. 2025;443:133969.
    PubMed     Abstract available
    
    
    
16. KOIZUMI T, Kato N, Inadome Y, Tabata F, et al
    CD163-positive macrophage enrichment in cardiogenic thrombi from atrial fibrillation than in atherosclerotic thrombi from sinus rhythm.
    Int J Cardiol. 2025 Oct 4:133941. doi: 10.1016/j.ijcard.2025.133941.
    PubMed     Abstract available
    
    
    September 2025
17. MATSUOKA Y, Sakamoto D, Sunaga A, Okada K, et al
    Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants.
    Int J Cardiol. 2025;443:133942.
    PubMed     Abstract available
    
    
    
18. OKUYAMA T
    Response to a comment re: "Impact of diagnosis-to-ablation time (DAT) on rhythm outcomes after catheter ablation for atrial fibrillation (AF)".
    Int J Cardiol. 2025 Sep 11:133892. doi: 10.1016/j.ijcard.2025.133892.
    PubMed    
    
    
    
19. LU Y, Liu Y, Zhang Y, Wang H, et al
    Global burden of early-onset atrial fibrillation and flutter: Population based study.
    Int J Cardiol. 2025 Sep 6:133862. doi: 10.1016/j.ijcard.2025.133862.
    PubMed     Abstract available
    
    
    
20. VELT MJH, Mulder BA
    Reply to letters to the editor part 1: Duration of atrial fibrillation and cardiac biomarkers: Data from the RACE II study.
    Int J Cardiol. 2025 Sep 2:133849. doi: 10.1016/j.ijcard.2025.133849.
    PubMed    
    
    
    
21. VELT MJH, Mulder BA
    Reply to letters to the editor part 2: Duration of atrial fibrillation and cardiac biomarkers: Data from the RACE II study.
    Int J Cardiol. 2025 Sep 1:133850. doi: 10.1016/j.ijcard.2025.133850.
    PubMed    
    
    
    August 2025
22. SHAWKI M, Sampaio Rodrigues T, Khabazi KP, Brick C, et al
    Short-term incidence and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy receiving cardiac myosin inhibitors: A systematic review and meta-analysis.
    Int J Cardiol. 2025;442:133846.
    PubMed     Abstract available
    
    
    
23. CHONAN Y, Suzuki H, Takeuchi K, Takanami K, et al
    Insular abnormalities in (18)F-fluorodeoxyglucose positron emission tomography and risk of fatal ventricular arrhythmic events in patients with cardiac sarcoidosis.
    Int J Cardiol. 2025;441:133814.
    PubMed     Abstract available
    
    
    
24. YU H
    Letter to editor: Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.
    Int J Cardiol. 2025 Aug 9:133761. doi: 10.1016/j.ijcard.2025.133761.
    PubMed    
    
    
    
25. LIU X, Zhang Y
    Comment on:"Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study".
    Int J Cardiol. 2025 Aug 7:133741. doi: 10.1016/j.ijcard.2025.133741.
    PubMed    
    
    
    
26. ZHANG L, Luo Z, Lin R
    Comment on"impact of diagnosis-to-ablation time on rhythm outcome after catheter ablation for paroxysmal versus non-paroxysmal atrial fibrillation".
    Int J Cardiol. 2025 Aug 7:133735. doi: 10.1016/j.ijcard.2025.133735.
    PubMed    
    
    
    
27. LOHANO G, Lohano G, Das R, Lohana S, et al
    Letter to the editor: Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.
    Int J Cardiol. 2025 Aug 6:133728. doi: 10.1016/j.ijcard.2025.133728.
    PubMed    
    
    
    
28. HUA W, Qiao F, Tang W
    Comment on duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.
    Int J Cardiol. 2025 Aug 6:133727. doi: 10.1016/j.ijcard.2025.133727.
    PubMed    
    
    
    
29. SU Z, Zhang P, He Z
    Association between atrial fibrillation duration, cardiac biomarkers, and cardiovascular outcomes in early permanent atrial fibrillation.
    Int J Cardiol. 2025 Aug 6:133733. doi: 10.1016/j.ijcard.2025.133733.
    PubMed    
    
    
    
30. SHAMSULDDIN AB
    Beyond time alone: Reframing the definition of permanent atrial fibrillation with biomarkers.
    Int J Cardiol. 2025 Aug 5:133720. doi: 10.1016/j.ijcard.2025.133720.
    PubMed    
    
    
    
31. DHANKA S, Maini S
    A hybrid machine learning approach using particle swarm optimization for cardiac arrhythmia classification.
    Int J Cardiol. 2025;432:133266.
    PubMed     Abstract available
    
    
    July 2025
32. VELT MJH, van Gelder IC, Crijns HJGM, Rienstra M, et al
    Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.
    Int J Cardiol. 2025;439:133669.
    PubMed     Abstract available
    
    
    
33. OKUYAMA T, Watanabe T, Hoshide S, Suda N, et al
    Impact of diagnosis-to-ablation time on rhythm outcome after catheter ablation for paroxysmal versus non-paroxysmal atrial fibrillation.
    Int J Cardiol. 2025;439:133667.
    PubMed     Abstract available
    
    
    
34. MALANCHINI G, Celentano E
    Reply to Comment on "Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter defibrillators: A propensity score-matched analysis".
    Int J Cardiol. 2025;439:133619.
    PubMed    
    
    
    
35. GAO S, Yan Y, Liu L
    Navigating pharmacotherapy in heart failure complicated by atrial fibrillation: A practical summary.
    Int J Cardiol. 2025;439:133640.
    PubMed    
    
    
    
36. GUELI IA, Aimo A, Alderotti B, Trimarchi G, et al
    Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2025;431:133224.
    PubMed     Abstract available
    
    
    
37. ZHANG J, Wang L, Li Y, Li Q, et al
    Atrial fibrillation phenotypes identified through cluster analysis in the CABANA study.
    Int J Cardiol. 2025;438:133606.
    PubMed     Abstract available
    
    
    
38. MAGNANI JW, Plevniak K, Ferry D, Martin D, et al
    The mobile health intervention for rural patients with atrial fibrillation a randomized controlled trial.
    Int J Cardiol. 2025 Jul 1:133575. doi: 10.1016/j.ijcard.2025.133575.
    PubMed     Abstract available
    
    
    June 2025
39. MERT GO, Spartalis M, Murat S, Gorenek B, et al
    Commentary on ventricular arrhythmias in acute heart failure: Critical insights into the 2024 ESC-EHRA-ACVC-HFA consensus.
    Int J Cardiol. 2025 Jun 24:133544. doi: 10.1016/j.ijcard.2025.133544.
    PubMed     Abstract available
    
    
    
40. THANGJUI S, Trongtorsak A, Kewcharoen J, Balla S, et al
    Post-cardioversion anticoagulation in atrial fibrillation with left atrial appendage occlusion: Necessary or not?
    Int J Cardiol. 2025;438:133518.
    PubMed     Abstract available
    
    
    
41. LONG X, Li J
    Letter to the editor: Independent effect of influenza vaccination on all-cause mortality in critically ill patients with atrial fibrillation: A retrospective study from the MIMIC-IV database.
    Int J Cardiol. 2025;437:133502.
    PubMed    
    
    
    
42. LONG X
    Comment on "Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis".
    Int J Cardiol. 2025;437:133501.
    PubMed    
    
    
    
43. SU B, Zhao J, Dai X, Ma C, et al
    A novel algorithm based on left atrial strain parameters in patients with non-valvular atrial fibrillation could identify the thrombogenic milieu of left atrial appendage.
    Int J Cardiol. 2025;437:133498.
    PubMed     Abstract available
    
    
    
44. DILAVERIS P, Siasos G
    Nationwide, Danish data may assist in refining ischemic stroke risk prediction in atrial fibrillation.
    Int J Cardiol. 2025;437:133460.
    PubMed    
    
    
    
45. SHIMADA T, Fukuda D, Shibata A, Ito A, et al
    Risk stratification of net adverse clinical events using CHADS-P(2)A(2)RC and CHADS(2) scores in chronic coronary syndrome patients without atrial fibrillation: Insights from the CLIDAS-PCI.
    Int J Cardiol. 2025;437:133464.
    PubMed     Abstract available
    
    
    
46. LAZZARI L, Donzelli S, Marallo C, Tordini A, et al
    Development and validation of an ECG algorithm based on lead V3 morphology to determine the origin of outflow tract ventricular arrhythmias.
    Int J Cardiol. 2025;436:133446.
    PubMed     Abstract available
    
    
    May 2025
47. LIU ZB, Wang Y, Liu J, Ding SF, et al
    Combination of colchicine and bifidobacteria: A promising strategy for reducing the recurrence of atrial fibrillation.
    Int J Cardiol. 2025 May 27:133440. doi: 10.1016/j.ijcard.2025.133440.
    PubMed    
    
    
    
48. ZHAO P, Zhang T
    Letter to "U-shaped relationship between serum phosphate levels and mortality in critically ill patients with atrial fibrillation: Insights from the MIMIC-IV database".
    Int J Cardiol. 2025 May 27:133430. doi: 10.1016/j.ijcard.2025.133430.
    PubMed    
    
    
    
49. AKKAYA F, Hosoglu Y
    Is female sex still a driver of stroke risk in atrial fibrillation?
    Int J Cardiol. 2025 May 27:133442. doi: 10.1016/j.ijcard.2025.133442.
    PubMed    
    
    
    
50. SONG Y, Li M, Zhang Z
    Comment on "impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes".
    Int J Cardiol. 2025 May 27:133441. doi: 10.1016/j.ijcard.2025.133441.
    PubMed    
    
    
    
51. CERSOSIMO A, Arabia G, Cerini M, Calvi E, et al
    Predictive value of left and right atrial strain for the detection of device-detected atrial fibrillation in patients with cryptogenic stroke and implantable cardiac monitor.
    Int J Cardiol. 2025 May 21:133368. doi: 10.1016/j.ijcard.2025.133368.
    PubMed     Abstract available
    
    
    
52. ZHOU M, Chen J, Behera TR, Shen Q, et al
    Editorial: Phosphate paradox: The U-shaped mortality curve in critically ill patients with atrial fibrillation.
    Int J Cardiol. 2025;435:133399.
    PubMed    
    
    
    
53. BASEM M, Bonnesen K, Szentkuti P, Horvath-Puho E, et al
    Interaction between atrial fibrillation or flutter and the CHA(2)DS(2)-VASc score on the risk of ischemic stroke: A population-based cohort study.
    Int J Cardiol. 2025;435:133397.
    PubMed     Abstract available
    
    
    
54. LIU ZB, Lu Q, Liu J, Ding SF, et al
    Combination of colchicine and berberine for reducing atrial fibrillation recurrence post-ablation and preventing postoperative atrial fibrillation: A promising approach?
    Int J Cardiol. 2025;435:133393.
    PubMed     Abstract available
    
    
    
55. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
    Response to SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
    Int J Cardiol. 2025 May 15:133396. doi: 10.1016/j.ijcard.2025.133396.
    PubMed    
    
    
    
56. YICHI Y, Xiaomin Y, Jian S, Pengpai Z, et al
    Routine preoperative transthoracic echocardiography for predicting incomplete endothelialization of the watchman left atrial appendage occluder: A single-center five-year study.
    Int J Cardiol. 2025 May 15:133385. doi: 10.1016/j.ijcard.2025.133385.
    PubMed     Abstract available
    
    
    
57. SHEN J, Ge L, Chen L, Qiu B, et al
    Left atrial low voltage areas predicts clinical stroke after radiofrequency ablation in patients with atrial fibrillation.
    Int J Cardiol. 2025 May 11:133366. doi: 10.1016/j.ijcard.2025.133366.
    PubMed     Abstract available
    
    
    
58. TUKKER M, Te Rijdt WP, Amin AS, Morris-Rosendahl DJ, et al
    High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature.
    Int J Cardiol. 2025 May 6:133350. doi: 10.1016/j.ijcard.2025.133350.
    PubMed     Abstract available
    
    
    April 2025
59. MALANCHINI G, Celentano E, Curnis A, Rovaris G, et al
    Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis.
    Int J Cardiol. 2025;433:133323.
    PubMed     Abstract available
    
    
    
60. FAN ZX, Huang YF
    Targeting the SPP1/TGF-beta1 axis in macrophages: A potential therapeutic mechanism for atrial fibrillation?
    Int J Cardiol. 2025;433:133312.
    PubMed    
    
    
    
61. JUNGEN C, Mathew S
    Advancing the treatment of persistent atrial fibrillation - Lessons from vein of Marshall ethanol infusion.
    Int J Cardiol. 2025 Apr 17:133271. doi: 10.1016/j.ijcard.2025.133271.
    PubMed    
    
    
    
62. HE Y, Huang J, Huang S, Li Y, et al
    U-shaped relationship between serum phosphate levels and mortality in critically ill patients with atrial fibrillation: Insights from the MIMIC-IV database.
    Int J Cardiol. 2025 Apr 15:133283. doi: 10.1016/j.ijcard.2025.133283.
    PubMed     Abstract available
    
    
    
63. LEI J, Zheng LZ, Chen KY, Yang X, et al
    Independent effect of influenza vaccination on all-cause mortality in critically ill patients with atrial fibrillation: A retrospective study from the MIMIC-IV database.
    Int J Cardiol. 2025;433:133246.
    PubMed     Abstract available
    
    
    
64. LEE JH, Lee SR, Cho Y, Oh IY, et al
    Clinical outcomes associated with Insertable cardiac monitor implantation in Korea: A Nationwide claims data analysis.
    Int J Cardiol. 2025;432:133265.
    PubMed     Abstract available
    
    
    March 2025
65. FAN ZX, Wu JC, Yang J
    SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
    Int J Cardiol. 2025;430:133206.
    PubMed    
    
    
    
66. YANG L, Yuan Z, Chen Y, Zeng Y, et al
    Plasma expression level of Hsa_circ_0099734 is associated with atrial fibrillation and its poor prognosis.
    Int J Cardiol. 2025 Mar 24:133202. doi: 10.1016/j.ijcard.2025.133202.
    PubMed     Abstract available
    
    
    
67. CESARO A, Acerbo V, Gragnano F, Calabro P, et al
    SGLT2 Inhibitors in atrial fibrillation: Ready for prime time?
    Int J Cardiol. 2025;430:133186.
    PubMed    
    
    
    
68. YANG J, He L, Yuan D
    A new predictive tool of ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
    Int J Cardiol. 2025;430:133190.
    PubMed    
    
    
    
69. SCHIANO C, Infante T, Benincasa G, Burrello J, et al
    DNA hypermethylation of MED1 and MED23 as early diagnostic biomarkers for unsolved issues in atrial fibrillation.
    Int J Cardiol. 2025 Mar 18:133179. doi: 10.1016/j.ijcard.2025.133179.
    PubMed     Abstract available
    
    
    
70. HAYASHI Y, Igarashi M, Yamasaki H, Iioka Y, et al
    Impact of radiofrequency versus cryoballoon ablation on left atrial calcification after atrial fibrillation ablation: A propensity score-matched comparison.
    Int J Cardiol. 2025 Mar 18:133177. doi: 10.1016/j.ijcard.2025.133177.
    PubMed     Abstract available
    
    
    
71. LUO B, Ma Z, Liu X, Liu T, et al
    Long-term effects of catheter ablation with vein of Marshall ethanol infusion vs. pulmonary vein isolation alone on persistent atrial fibrillation.
    Int J Cardiol. 2025 Mar 14:133130. doi: 10.1016/j.ijcard.2025.133130.
    PubMed     Abstract available
    
    
    
72. CHEN S, Liu Q, Yin X, Xiao F, et al
    12-month outcomes of pulsed-field ablation with a variable-diameter circular catheter for paroxysmal atrial fibrillation: Insights into conscious sedation and fluoroscopy use.
    Int J Cardiol. 2025 Mar 10:133135. doi: 10.1016/j.ijcard.2025.133135.
    PubMed     Abstract available
    
    
    
73. HU Y, Li C, Li Y, Wu X, et al
    Steps to improve the outcome of a single ablation procedure for paroxysmal atrial fibrillation: Significance of a burst stimulation-guided ablation strategy.
    Int J Cardiol. 2025;428:133132.
    PubMed     Abstract available
    
    
    
74. LIANG E, Kang L, Song W, Du Z, et al
    Vagal response during radiofrequency catheter ablation initiated from right superior pulmonary vein: Incidence, risk factors, and clinical outcomes.
    Int J Cardiol. 2025;422:132915.
    PubMed     Abstract available
    
    
    February 2025
75. FAN ZX, Xu XF, Yang CJ
    Combination of colchicine and omega-3 fatty acids for reducing the recurrence of atrial fibrillation: A promising approach?
    Int J Cardiol. 2025;426:133100.
    PubMed    
    
    
    
76. AMEER MZ, Rehman AU, Amjad Z, Khan S, et al
    Cardiovascular outcomes with SGLT-2 inhibitors in individuals with diabetes and co-existing atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2025;426:133083.
    PubMed     Abstract available
    
    
    
77. OZLEK B, Barutcu S, Prof A
    Colchicine and post-ablation atrial fibrillation recurrence: How effective is it?
    Int J Cardiol. 2025;426:133089.
    PubMed    
    
    
    
78. DELL'ERA G, Palmisano P, Bertini M, Magnano M, et al
    Real-world adoption of left bundle branch area pacing: Insights from the Conduction-System pacing Italian Network Group (C-SING).
    Int J Cardiol. 2025;421:132879.
    PubMed     Abstract available
    
    
    
79. OUCHI K, Sakuma T, Kisaki S, Tokutake K, et al
    Left atrial changes and B-type natriuretic peptide levels after pulmonary vein isolation for atrial fibrillation.
    Int J Cardiol. 2025;425:133053.
    PubMed     Abstract available
    
    
    
80. GAO X, Xie B, Zhao Z, Chen K, et al
    Reply to Letter to the Editor for the "NSUN2/PARP1 signaling axis: A potential mechanism for treating aging associated atrial fibrillation".
    Int J Cardiol. 2025 Feb 4:133042. doi: 10.1016/j.ijcard.2025.133042.
    PubMed    
    
    
    January 2025
81. YETKIN E
    Recurrence of atrial fibrillation: Low dose colchicine and allopurinol.
    Int J Cardiol. 2025 Jan 27:133013. doi: 10.1016/j.ijcard.2025.133013.
    PubMed    
    
    
    
82. FENDER AC, Bruns F, Dobrev D
    Sex and atrial fibrillation-associated risk estimation and management.
    Int J Cardiol. 2025;423:133000.
    PubMed    
    
    
    
83. FAN ZX, Yang J
    NSUN2/PARP1 signaling axis: A potential mechanism for treating aging-associated atrial fibrillation.
    Int J Cardiol. 2025;422:132993.
    PubMed    
    
    
    
84. CASULA M, Scajola LV, Quilico F, Pasotti B, et al
    Posterior left atrial wall isolation for treatment of persistent atrial fibrillation during first-time catheter ablation: An updated systematic review and meta-analysis.
    Int J Cardiol. 2025;422:132987.
    PubMed     Abstract available
    
    
    
85. GRANCHIETTI AG, Ciardetti N, Mazzoni C, Garofalo M, et al
    Left atrial strain and risk of atrial fibrillation after coronary artery bypass-grafting.
    Int J Cardiol. 2025;422:132981.
    PubMed     Abstract available
    
    
    
86. AL-SADAWI M, Aslam F, Henriques MD, Alsaiqali M, et al
    Effect of low dose colchicine on long term recurrence after atrial fibrillation ablation.
    Int J Cardiol. 2025 Jan 8:132972. doi: 10.1016/j.ijcard.2025.132972.
    PubMed     Abstract available
    
    
    
87. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
    Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes.
    Int J Cardiol. 2025 Jan 2:132954. doi: 10.1016/j.ijcard.2024.132954.
    PubMed     Abstract available
    
    
    December 2024
88. GARCIA OO, de la Fuente-Lopez P, Cinza-Sanjurjo S, Cordero A, et al
    Gender-specific effects of delay in cardiology consultation following primary care physician referral in atrial fibrillation patients: Impact on one-year outcomes.
    Int J Cardiol. 2024 Dec 30:132947. doi: 10.1016/j.ijcard.2024.132947.
    PubMed     Abstract available
    
    
    
89. JASON MJ, Marzec LN, Piccini JP, Shrader P, et al
    Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry.
    Int J Cardiol. 2024 Dec 19:132912. doi: 10.1016/j.ijcard.2024.132912.
    PubMed     Abstract available
    
    
    
90. DE SIO V, Gragnano F, Capolongo A, Terracciano F, et al
    Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions.
    Int J Cardiol. 2024 Dec 19:132921. doi: 10.1016/j.ijcard.2024.132921.
    PubMed     Abstract available
    
    
    
91. WANG G, Liu T, Ji W, Wang N, et al
    Prolonged elevated heart rate is association with adverse outcome in severe pulmonary embolism: A retrospective study.
    Int J Cardiol. 2024;417:132581.
    PubMed     Abstract available
    
    
    
92. LOPEZ J, Duarte G, Mark JD, Vergara Sanchez C, et al
    Impact of cardiac conduction disease in patients with cardiac amyloidosis: A national retrospective cohort study.
    Int J Cardiol. 2024;417:132468.
    PubMed     Abstract available
    
    
    
93. DAMIANI D, Agosta VT, D'Andria Ursoleo J, Bottussi A, et al
    Perioperative and long-term outcomes of bilateral cardiac sympathetic denervation via video-assisted thoracoscopic surgery in patients with refractory ventricular arrhythmias.
    Int J Cardiol. 2024;421:132890.
    PubMed     Abstract available
    
    
    
94. CALIK KUTUKCU E
    The one-minute sit-to-stand test: A novel tool for assessing functional capacity in patients with atrial fibrillation.
    Int J Cardiol. 2024;421:132896.
    PubMed    
    
    
    
95. CESMAT AP, Chaudry AM, Gupta S, Weickert TT, et al
    Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.
    Int J Cardiol. 2024;421:132888.
    PubMed     Abstract available
    
    
    
96. PREDA A, Falasconi G, Melillo F, Margonato D, et al
    Left atrial appendage closure in patients with failure of anticoagulation therapy: A multicenter comparative study on the hybrid strategy using DOACs and VKAs.
    Int J Cardiol. 2024;421:132875.
    PubMed     Abstract available
    
    
    
97. CAMM CJF, Virdone S, Jerjes-Sanchez C, Oh S, et al
    Association of care specialty with anticoagulant prescription and clinical outcomes in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry.
    Int J Cardiol. 2024 Dec 2:132866. doi: 10.1016/j.ijcard.2024.132866.
    PubMed     Abstract available
    
    
    November 2024
98. LIONCINO M, Placidi S, Calcagni G, Drago F, et al
    Reply: Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
    Int J Cardiol. 2024 Nov 18:132732. doi: 10.1016/j.ijcard.2024.132732.
    PubMed    
    
    
    
99. XU B, Wang Y, Zhao C, Yu Z, et al
    Identifying left atrium and left atrial appendage prone to thrombus formation in patients with atrial fibrillation using statistical shape modeling.
    Int J Cardiol. 2024 Nov 17:132731. doi: 10.1016/j.ijcard.2024.132731.
    PubMed     Abstract available
    
    
    
100. NEDIOS S, Arentz T
     Navigating pregnancy: Considerations for ablating atrial tachycardias.
     Int J Cardiol. 2024;415:132474.
     PubMed    
     
     
     
101. LAURSEN SB, Pareek M, Polcwiartek C, Kristensen AMD, et al
     High-sensitivity cardiac troponin-T concentrations and their prognostic implications in patients with paroxysmal supraventricular tachycardia.
     Int J Cardiol. 2024 Nov 14:132717. doi: 10.1016/j.ijcard.2024.132717.
     PubMed     Abstract available
     
     
     
102. KAWAJI T, Hamatani Y, Kato M, Yokomatsu T, et al
     Bundle branch block patterns during atrial fibrillation rhythm for heart failure events.
     Int J Cardiol. 2024 Nov 9:132710. doi: 10.1016/j.ijcard.2024.132710.
     PubMed     Abstract available
     
     
     
103. OZEL CB, Ozdemir HY, Dural M, Al A, et al
     The one-minute sit-to-stand test is an alternative to the 6-minute walk test in patients with atrial fibrillation: A cross-sectional study and ROC curve analysis.
     Int J Cardiol. 2024 Nov 7:132713. doi: 10.1016/j.ijcard.2024.132713.
     PubMed     Abstract available
     
     
     
104. SCHINDLER TH, Eslambolchi A, Ozkan E
     Mild basal interventricular inflammation as a predictor of ventricular arrhythmia?
     Int J Cardiol. 2024;419:132715.
     PubMed    
     
     
     October 2024
105. TAKEUCHI K, Suzuki H, Takanami K, Ota H, et al
     Reduced (18)F-FDG uptake in the basal interventricular septum as a predictor of fatal ventricular arrhythmic events in patients with cardiac sarcoidosis.
     Int J Cardiol. 2024 Oct 25:132686. doi: 10.1016/j.ijcard.2024.132686.
     PubMed     Abstract available
     
     
     
106. DEL FRANCO A, Argiro A, Bonacchi G, Cappelli F, et al
     Left ventricular late gadolinium enhancement for prediction of atrial fibrillation in hypertrophic cardiomyopathy: A good neighbour warns of the danger.
     Int J Cardiol. 2024;419:132662.
     PubMed    
     
     
     
107. CHEN M, Pang B, Li G, Wang Y, et al
     Predictive value of apical rocking and septal flash for subclinical left ventricular systolic dysfunction in complete left bundle branch block patients with normal left ventricular ejection fraction.
     Int J Cardiol. 2024 Oct 24:132683. doi: 10.1016/j.ijcard.2024.132683.
     PubMed     Abstract available
     
     
     
108. MINAMI K, Machino-Ohtsuka T, Nakatsukasa T, Kawamatsu N, et al
     Clinical significance of echocardiographic left ventricular hypertrophy for predicting left atrial appendage thrombotic milieu in patients with atrial fibrillation and CHA(2)DS(2)-VASc scores of 0-2.
     Int J Cardiol. 2024;419:132682.
     PubMed     Abstract available
     
     
     
109. LIU Y, Dai W
     Letter to the Editor: Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
     Int J Cardiol. 2024 Oct 22:132679. doi: 10.1016/j.ijcard.2024.132679.
     PubMed    
     
     
     
110. VENTRELLA N, Schiavone M, Bianchini L, Sicuso R, et al
     Catheter ablation for focal atrial tachycardias during pregnancy: A systematic review.
     Int J Cardiol. 2024;413:132333.
     PubMed     Abstract available
     
     
     
111. ARABIA G, Colangelo M, Borrello F, Curnis A, et al
     Usefulness of last generation insertable cardiac monitors in the diagnosis of unexplained syncope.
     Int J Cardiol. 2024;413:132301.
     PubMed     Abstract available
     
     
     
112. LI G, Ma Z, Lu Y, Jiang Y, et al
     Associations of socioeconomic status and chronic stress with incident atrial fibrillation among older adults: A prospective cohort study from the UK biobank.
     Int J Cardiol. 2024;418:132633.
     PubMed     Abstract available
     
     
     
113. GAROT P, Gall E, Zendjebil S, Cepas-Guillen P, et al
     Left atrial appendage closure guided by fusion of 3D computational modelling on real-time fluoroscopy: A multicenter experience.
     Int J Cardiol. 2024;418:132614.
     PubMed     Abstract available
     
     
     
114. YAN Z, Pu X, Chang X, Liu Z, et al
     Genetic basis and causal relationship between atrial fibrillation and sinus node dysfunction: Evidence from comprehensive genetic analysis.
     Int J Cardiol. 2024 Oct 8:132609. doi: 10.1016/j.ijcard.2024.132609.
     PubMed     Abstract available
     
     
     
115. VELT MJH, Rienstra M, Mulder BA
     Reply to: Biomarkers in paroxysmal atrial fibrillation during an acute episode: The cause or the result?
     Int J Cardiol. 2024;418:132622.
     PubMed    
     
     
     
116. NIELSEN-KUDSK JE, Korsholm K, Andersen A, Jensen JM, et al
     Real changes in left atrial appendage occlusion practice in Denmark over time or inappropriate use of registry data?
     Int J Cardiol. 2024;412:132350.
     PubMed    
     
     
     
117. BASILE P, Soldato N, Pedio E, Siena P, et al
     Cardiac magnetic resonance reveals concealed structural heart disease in patients with frequent premature ventricular contractions and normal echocardiography: A systematic review.
     Int J Cardiol. 2024;412:132306.
     PubMed     Abstract available
     
     
     
118. CLEMENTE MRC, Navalha DDP, Bittar V, Costa TA, et al
     Combined left atrial appendage occlusion and catheter ablation for atrial fibrillation versus isolated left atrial appendage occlusion: A systematic review and meta-analysis.
     Int J Cardiol. 2024 Oct 1:132597. doi: 10.1016/j.ijcard.2024.132597.
     PubMed     Abstract available
     
     
     September 2024
119. PLACIDI S, Calcagni G, Lioncino M, Calvieri C, et al
     Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
     Int J Cardiol. 2024 Sep 24:132599. doi: 10.1016/j.ijcard.2024.132599.
     PubMed     Abstract available
     
     
     
120. XIAO X
     Biomarkers in paroxysmal atrial fibrillation during an acute episode: The cause or the result?
     Int J Cardiol. 2024 Sep 19:132589. doi: 10.1016/j.ijcard.2024.132589.
     PubMed    
     
     
     
121. XIAO X
     Fibroblast growth factor 5: A novel and promising therapeutic target in atrial fibrillation.
     Int J Cardiol. 2024 Sep 19:132586. doi: 10.1016/j.ijcard.2024.132586.
     PubMed    
     
     
     
122. MIYAMOTO S, Tokuyama T, Okubo Y, Okamura S, et al
     Decreased plasma cell-free mitochondrial DNA may be a new biomarker of tachycardia-induced cardiomyopathy in patients with atrial fibrillation.
     Int J Cardiol. 2024 Sep 19:132579. doi: 10.1016/j.ijcard.2024.132579.
     PubMed     Abstract available
     
     
     
123. BOTTO GL, Capranzano P, Colonna P, Fornasari DMM, et al
     Use of DOACs in frail elderly patients in light of class genericization.
     Int J Cardiol. 2024;411:132276.
     PubMed     Abstract available
     
     
     
124. YAFASOV M, Olsen FJ, Hauser R, Skaarup KG, et al
     Left atrial strain measured by three-dimensional echocardiography predicts atrial fibrillation in the general population.
     Int J Cardiol. 2024;417:132544.
     PubMed     Abstract available
     
     
     
125. AKDIS D, Weidmann L, Guan F, Bachmann M, et al
     Clinical experience of pulmonary vein isolation via single transseptal puncture in atrial fibrillation patients: Comprehensive characterization and follow-up.
     Int J Cardiol. 2024 Sep 12:132557. doi: 10.1016/j.ijcard.2024.132557.
     PubMed     Abstract available
     
     
     
126. TACHIBANA S, Inaba O, Inamura Y, Takagi T, et al
     Segmental evaluation of predictive value of left atrial epicardial adipose tissue following catheter ablation for atrial fibrillation.
     Int J Cardiol. 2024;417:132558.
     PubMed     Abstract available
     
     
     
127. MENE R, Sousonis V, Schmidt B, Bordignon S, et al
     Safety and efficacy of pulsed-field ablation for atrial fibrillation in the elderly: A EU-PORIA sub-analysis.
     Int J Cardiol. 2024;417:132522.
     PubMed     Abstract available
     
     
     
128. LAN Z, Cheng S, Han Y, Jiang L, et al
     Predictive value of fine fibrillatory wave for declining eGFR in patients with persistent atrial fibrillation: Long-term follow-up study.
     Int J Cardiol. 2024;417:132521.
     PubMed     Abstract available
     
     
     
129. VELT MJH, Crijns HJGM, van Gelder IC, Linz D, et al
     Dynamic biomarker profiles in patients with paroxysmal atrial fibrillation: Assessing the differences between sinus rhythm and acute atrial fibrillation episode.
     Int J Cardiol. 2024;417:132526.
     PubMed     Abstract available
     
     
     
130. WAFA SEI, Sawatari H, Ahmed R, Deshpande S, et al
     CHA(2)DS(2)-VASc predicts readmission, outcomes and resource utilization in patients undergoing coronary artery bypass grafting: A 7-year National Readmission Database study.
     Int J Cardiol. 2024 Sep 5:132529. doi: 10.1016/j.ijcard.2024.132529.
     PubMed     Abstract available
     
     
     
131. JUNG M, Kim SW, Park JW
     Trends in percutaneous left atrial appendage occlusion and 1-year mortality 2013-2021: A nationwide observational study.
     Int J Cardiol. 2024;410:132222.
     PubMed    
     
     
     August 2024
132. FAN K, Xiao Y, Xue A, Zhou J, et al
     Clinical outcomes, management, healthcare resource utilization, and cost according to the CHA(2)DS(2)-VASc scores in Asian patients with nonvalvular atrial fibrillation.
     Int J Cardiol. 2024 Aug 28:132496. doi: 10.1016/j.ijcard.2024.132496.
     PubMed     Abstract available
     
     
     
133. LIU T, Yang X, Jia R, Han J, et al
     Left atrial mechanical dispersion and left atrial stiffness predicts recurrence of atrial fibrillation: In patients with moderate-severe rheumatic mitral stenosis.
     Int J Cardiol. 2024 Aug 26:132480. doi: 10.1016/j.ijcard.2024.132480.
     PubMed     Abstract available
     
     
     
134. PALARETI G, Testa S, Legnani C, Paoletti O, et al
     The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events.
     Int J Cardiol. 2024 Aug 24:132484. doi: 10.1016/j.ijcard.2024.132484.
     PubMed     Abstract available
     
     
     
135. WEI Z, Lu Y, Qian C, Li J, et al
     Circ_0079480 facilitates proliferation, migration and fibrosis of atrial fibroblasts in atrial fibrillation by sponing miR-338-3p to activate the THBS1/TGF-beta1/Smad3 signaling.
     Int J Cardiol. 2024 Aug 24:132486. doi: 10.1016/j.ijcard.2024.132486.
     PubMed     Abstract available
     
     
     
136. WU S, Shang W, Ye Y, Su L, et al
     Sex differences outcomes in conduction system pacing for patients with typical left bundle branch block.
     Int J Cardiol. 2024 Aug 22:132475. doi: 10.1016/j.ijcard.2024.132475.
     PubMed     Abstract available
     
     
     
137. DURAK H, Ergul E
     Association of induced atrial fibrillation in the electrophysiology laboratory with endothelial dysfunction and documented atrial fibrillation.
     Int J Cardiol. 2024;415:132465.
     PubMed     Abstract available
     
     
     
138. ROMANOV A, Nikitin N
     Epicardial adipose tissue for atrial arrhythmias prediction in coronary artery disease. Are we close to the gold marker?
     Int J Cardiol. 2024;409:132176.
     PubMed    
     
     
     
139. PICCOLO S, Casal M, Rossi V, Ferrigni F, et al
     Ventricular arrhythmias and primary prevention of sudden cardiac death in Anderson-Fabry disease.
     Int J Cardiol. 2024;415:132444.
     PubMed     Abstract available
     
     
     
140. JIANG L, Zhang X, Ding SA, Tang M, et al
     Simultaneous thoracoscopic surgery in patients with atrial fibrillation and early-stage lung cancer.
     Int J Cardiol. 2024 Aug 2:132422. doi: 10.1016/j.ijcard.2024.132422.
     PubMed     Abstract available
     
     
     July 2024
141. BALL J, Mahony E, Nehme E, Voskoboinik A, et al
     The burden of atrial fibrillation on emergency medical services: A population-based cohort study.
     Int J Cardiol. 2024 Jul 29:132397. doi: 10.1016/j.ijcard.2024.132397.
     PubMed     Abstract available
     
     
     
142. GAO C, Wang W, Jia H
     Fibroblast growth factor 5 as a target for atrial fibrillation treatment: Evidence from mendelian randomization.
     Int J Cardiol. 2024;413:132393.
     PubMed     Abstract available
     
     
     
143. ANDREA B, Anna D, Daniele B, Angelica C, et al
     H(2)FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation.
     Int J Cardiol. 2024 Jul 18:132385. doi: 10.1016/j.ijcard.2024.132385.
     PubMed     Abstract available
     
     
     
144. AMANO M, Takegami M, Miyake M, Kitai T, et al
     Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation.
     Int J Cardiol. 2024 Jul 16:132375. doi: 10.1016/j.ijcard.2024.132375.
     PubMed     Abstract available
     
     
     
145. ZHANG Z, Xiao Y, Wang C, Zhou J, et al
     Pulsed field ablation: A promising approach for ventricular tachycardia ablation.
     Int J Cardiol. 2024;407:131985.
     PubMed     Abstract available
     
     
     
146. ZHANG X, Zhang Y, Sun G, Li Z, et al
     Effectiveness of sodium-glucose co-transporter 2 inhibitors on atrial fibrillation recurrence after catheter ablation: A systemic review and meta-analysis.
     Int J Cardiol. 2024;413:132359.
     PubMed     Abstract available
     
     
     
147. ALBANI S, Merlo M
     Left ventricle late gadolinium enhancement and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy: Another brick towards a precise approach.
     Int J Cardiol. 2024;413:132357.
     PubMed    
     
     
     
148. GIOMI A, Bernardini A, Perini AP, Ciliberti D, et al
     Clinical impact of smoking on atrial fibrillation recurrence after pulmonary vein isolation.
     Int J Cardiol. 2024 Jul 4:132342. doi: 10.1016/j.ijcard.2024.132342.
     PubMed     Abstract available
     
     
     
149. HEEGER CH, Alagjozovski H
     Editorial to: Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
     Int J Cardiol. 2024;412:132299.
     PubMed    
     
     
     
150. GU Z, Guo L, Liu C, Lip GYH, et al
     Real-world evidence of early rhythm control in patients with atrial fibrillation: A systematic review and meta-analysis.
     Int J Cardiol. 2024 Jul 2:132327. doi: 10.1016/j.ijcard.2024.132327.
     PubMed     Abstract available
     
     
     
151. TERSALVI G, Bossard M, Aeschbacher S, Wiencierz A, et al
     Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.
     Int J Cardiol. 2024 Jul 2:132320. doi: 10.1016/j.ijcard.2024.132320.
     PubMed     Abstract available
     
     
     
152. REN Y, Chen L, Liu J, Wu Y, et al
     Correlation of epicardial adipose tissue and inflammatory indices in patients with STEMI and implications for atrial arrhythmias.
     Int J Cardiol. 2024;406:132016.
     PubMed     Abstract available
     
     
     June 2024
153. DAN GA
     Resurrection of classical antiarrhythmic drugs.
     Int J Cardiol. 2024;412:132300.
     PubMed    
     
     
     
154. VIJ V, Ruf TF, Thambo JB, Vogt L, et al
     Contrast-free left atrial appendage occlusion in patients using the LAMBRE device.
     Int J Cardiol. 2024;405:131939.
     PubMed     Abstract available
     
     
     
155. WANG SR, Huang KC, Lin TT, Chuang SL, et al
     Corrigendum to "The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease" [International Journal of Cardiology 409 (2024) 132198].
     Int J Cardiol. 2024;411:132257.
     PubMed    
     
     
     
156. HOLLOWELL M, Banno J, Marsy D, Shrestha N, et al
     Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024 Jun 13:132263. doi: 10.1016/j.ijcard.2024.132263.
     PubMed     Abstract available
     
     
     
157. BERNARDINI A, Bindini L, Antonucci E, Berteotti M, et al
     Corrigendum to "Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation" [International Journal of Cardiology 407 (2024) 132088].
     Int J Cardiol. 2024 Jun 8:132226. doi: 10.1016/j.ijcard.2024.132226.
     PubMed    
     
     
     
158. SUNAGA A, Matsuoka Y, Nakatani D, Okada K, et al
     Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
     Int J Cardiol. 2024 Jun 3:132231. doi: 10.1016/j.ijcard.2024.132231.
     PubMed     Abstract available
     
     
     
159. KAUR H, Tao B, Silverman M, Healey JS, et al
     Recurrence of new-onset post-operative AF after cardiac surgery: detected by implantable loop recorders: A systematic review and Meta-analysis.
     Int J Cardiol. 2024;404:131930.
     PubMed     Abstract available
     
     
     May 2024
160. WAZZAN AAL, Taconne M, Rolle VL, Forsaa MI, et al
     Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain.
     Int J Cardiol. 2024 May 24:132167. doi: 10.1016/j.ijcard.2024.132167.
     PubMed     Abstract available
     
     
     
161. RELLA V, Maurizi N, Bernardini A, Brasca FM, et al
     Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2024 May 23:132202. doi: 10.1016/j.ijcard.2024.132202.
     PubMed     Abstract available
     
     
     
162. WANG SR, Huang KC, Lin TT, Chuang SL, et al
     The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
     Int J Cardiol. 2024 May 21:132198. doi: 10.1016/j.ijcard.2024.132198.
     PubMed     Abstract available
     
     
     
163. UKITA K, Egami Y, Yano M, Nishino M, et al
     Reply to "Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?".
     Int J Cardiol. 2024;409:132187.
     PubMed    
     
     
     
164. MALHI JK, Ibecheozor C, Chrispin J, Gilotra NA, et al
     Diagnostic and management strategies in cardiac sarcoidosis.
     Int J Cardiol. 2024;403:131853.
     PubMed     Abstract available
     
     
     
165. LOPEZ-PALOP R, Carrillo P, Lozano I
     Transient new-onset atrial fibrillaation during acute coronary syndrome: Transient arrhythmia, transient risk?
     Int J Cardiol. 2024 May 14:132163. doi: 10.1016/j.ijcard.2024.132163.
     PubMed    
     
     
     
166. AGUIAR-NEVES I, Sa Carvalho A, Diaz SO, Ribeiro Silva M, et al
     Sex-based differences and risk of recurrence in patients with atrial fibrillation undergoing pulmonary vein isolation.
     Int J Cardiol. 2024;409:132161.
     PubMed     Abstract available
     
     
     
167. ATTIA A, Hiram R
     Colchicine for the prevention of atrial fibrillation: Why do some studies say 'yes', and others say 'no'?
     Int J Cardiol. 2024;408:132110.
     PubMed    
     
     
     
168. AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
     Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
     Int J Cardiol. 2024;402:131819.
     PubMed     Abstract available
     
     
     April 2024
169. KIRCHHOF P, Bakhai A, de Asmundis C, de Groot JR, et al
     Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study.
     Int J Cardiol. 2024 Apr 30:132118. doi: 10.1016/j.ijcard.2024.132118.
     PubMed     Abstract available
     
     
     
170. MADSEN OJ, Lamberts M, Olesen JB, Hansen ML, et al
     Trends in percutaneous left atrial appendage occlusion and 1-year mortality 2013-2021: A nationwide observational study.
     Int J Cardiol. 2024 Apr 26:132098. doi: 10.1016/j.ijcard.2024.132098.
     PubMed     Abstract available
     
     
     
171. BERNARDINI A, Bindini L, Antonucci E, Berteotti M, et al
     Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation.
     Int J Cardiol. 2024 Apr 22:132088. doi: 10.1016/j.ijcard.2024.132088.
     PubMed     Abstract available
     
     
     
172. AL A, Babayigit E, Gorenek B
     Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?
     Int J Cardiol. 2024;406:132079.
     PubMed    
     
     
     
173. TIAN X, Zhang N, Korantzopoulos P, Bazoukis G, et al
     Efficacy and safety of colchicine for atrial fibrillation prevention: An updated meta-analysis of randomized controlled trials.
     Int J Cardiol. 2024;406:132068.
     PubMed     Abstract available
     
     
     
174. PINEIRO AL, Abu-Assi E, Bermudez IG, Caro VN, et al
     Is pre-diabetes a predictor of events in patients with atrial fibrillation?
     Int J Cardiol. 2024 Apr 20:132086. doi: 10.1016/j.ijcard.2024.132086.
     PubMed     Abstract available
     
     
     
175. MOON I, Park SY, Kim D, Park M, et al
     Incidence of atrial fibrillation in patients with renal infarction: A retrospective cohort analysis of the Korean national health insurance registry.
     Int J Cardiol. 2024 Apr 19:132075. doi: 10.1016/j.ijcard.2024.132075.
     PubMed     Abstract available
     
     
     
176. TOMER O, Horowitz-Cederboim S, Rivkin D, Meiner V, et al
     Variable clinical expression of a novel FLNC truncating variant in a large family.
     Int J Cardiol. 2024;401:131849.
     PubMed     Abstract available
     
     
     
177. PETERSEN JK, Butt JH, Yafasova A, Torp-Pedersen C, et al
     Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
     Int J Cardiol. 2024 Apr 6:132017. doi: 10.1016/j.ijcard.2024.132017.
     PubMed     Abstract available
     
     
     
178. MESSORI A, Mamone D, Rivano M, Romeo MR, et al
     Pulsed-field ablation for paroxysmal atrial fibrillation: An indirect comparison of effectiveness among three proprietary devices conducted in the absence of randomized trials.
     Int J Cardiol. 2024 Apr 5:132025. doi: 10.1016/j.ijcard.2024.132025.
     PubMed     Abstract available
     
     
     
179. ABU-ASSI E, Castro AL, Fernandez MC, Bermudez IG, et al
     Relative performance evaluation of four bleeding risk scores in atrial fibrillation patients. What does the new DOAC score provide?
     Int J Cardiol. 2024 Apr 3:132018. doi: 10.1016/j.ijcard.2024.132018.
     PubMed     Abstract available
     
     
     
180. SCHEEL PJ 3RD, Cartella I, Murray B, Gilotra NA, et al
     Role of genetics in inflammatory cardiomyopathy.
     Int J Cardiol. 2024;400:131777.
     PubMed     Abstract available
     
     
     March 2024
181. KARTAS A, Papazoglou AS, Moysidis DV, Despotopoulos S, et al
     Use of apixaban in adults with congenital heart disease and atrial arrhythmias: The PROTECT-AR study.
     Int J Cardiol. 2024 Mar 31:131993. doi: 10.1016/j.ijcard.2024.131993.
     PubMed     Abstract available
     
     
     
182. ABE K, Kitahara H, Suzuki S, Hiraga T, et al
     Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention.
     Int J Cardiol. 2024 Mar 21:131989. doi: 10.1016/j.ijcard.2024.131989.
     PubMed     Abstract available
     
     
     
183. HUANG S, Joshi A, Shi Z, Wei J, et al
     Combined polygenic scores for ischemic stroke risk factors aid risk assessment of ischemic stroke.
     Int J Cardiol. 2024 Mar 21:131990. doi: 10.1016/j.ijcard.2024.131990.
     PubMed     Abstract available
     
     
     
184. WENG F, Yan T, Zhu M, Zhu S, et al
     Performance of a non-irrigated bipolar radiofrequency ablation clamp on beating human hearts.
     Int J Cardiol. 2024;399:131749.
     PubMed     Abstract available
     
     
     
185. YANG X, Chen S, Song H, Shu R, et al
     Association between cardiac conduction block and cardiovascular disease and all-cause mortality: The kailuan study.
     Int J Cardiol. 2024;399:131666.
     PubMed     Abstract available
     
     
     
186. GUO J, Wang D, Jia J, Zhang J, et al
     Patterns of atrial fibrillation, relevant cardiac structural and functional changes predict functional and cognitive outcomes in patients with ischemic stroke and atrial fibrillation.
     Int J Cardiol. 2024 Mar 13:131966. doi: 10.1016/j.ijcard.2024.131966.
     PubMed     Abstract available
     
     
     
187. SHI S, Zhao Q, Wu G, Yan H, et al
     Variation and disparity in awareness of atrial fibrillation in China: A national cross-sectional study.
     Int J Cardiol. 2024 Mar 10:131957. doi: 10.1016/j.ijcard.2024.131957.
     PubMed     Abstract available
     
     
     
188. KREUTZ R, Kloss S, Enders D, Abdelgawwad K, et al
     Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation.
     Int J Cardiol. 2024 Mar 2:131894. doi: 10.1016/j.ijcard.2024.131894.
     PubMed     Abstract available
     
     
     
189. LI L, Qian S, Fu JY, Wang ZN, et al
     Comparing safety and efficacy: MemoLefort versus watchman for left atrial appendage closure.
     Int J Cardiol. 2024;398:131641.
     PubMed     Abstract available
     
     
     
190. VAN DER STUIJT W, Pepplinkhuizen S, de Veld JA, Quast ABE, et al
     Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator?
     Int J Cardiol. 2024;398:131639.
     PubMed     Abstract available
     
     
     February 2024
191. LESHEM Y, Etan T, Dolev Y, Nikolaevski-Berlin A, et al
     The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab.
     Int J Cardiol. 2024;397:131642.
     PubMed     Abstract available
     
     
     
192. ENGEL M, Shiel EA, Chelko SP
     Basic and translational mechanisms in inflammatory arrhythmogenic cardiomyopathy.
     Int J Cardiol. 2024;397:131602.
     PubMed     Abstract available
     
     
     
193. PIERONI M, Ciabatti M, Zocchi C, Tavanti V, et al
     Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis.
     Int J Cardiol. 2024;397:131603.
     PubMed     Abstract available
     
     
     
194. LIU CM, Chen WS, Chang SL, Hsieh YC, et al
     Use of artificial intelligence and I-score for prediction of recurrence before catheter ablation of atrial fibrillation.
     Int J Cardiol. 2024 Feb 13:131851. doi: 10.1016/j.ijcard.2024.131851.
     PubMed     Abstract available
     
     
     
195. CHEW DS, Sacks NC, Emden MR, Cyr PL, et al
     Catheter ablation for supraventricular tachycardia and health resource utilization and expenditures: A propensity-matched cohort study.
     Int J Cardiol. 2024 Feb 6:131831. doi: 10.1016/j.ijcard.2024.131831.
     PubMed     Abstract available
     
     
     
196. ZOU JH, Hua BT, Shao XX, Wang C, et al
     Redefining left bundle branch block from high-density electroanatomical mapping.
     Int J Cardiol. 2024 Feb 4:131830. doi: 10.1016/j.ijcard.2024.131830.
     PubMed     Abstract available
     
     
     
197. HOU Y, Yang H, Xu Y, Wang K, et al
     Hearing disorders, genetic predisposition, and risk of new-onset atrial fibrillation: A prospective cohort study in the UK biobank.
     Int J Cardiol. 2024 Feb 4:131829. doi: 10.1016/j.ijcard.2024.131829.
     PubMed     Abstract available
     
     
     January 2024
198. MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
     Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
     Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
     PubMed     Abstract available
     
     
     
199. UKITA K, Egami Y, Nohara H, Kawanami S, et al
     Predictors of 30-day survival after emergent percutaneous coronary intervention following ventricular Tachyarrhythmias complicating acute myocardial infarction.
     Int J Cardiol. 2024 Jan 21:131806. doi: 10.1016/j.ijcard.2024.131806.
     PubMed     Abstract available
     
     
     
200. CORRADO D, Anastasakis A, Basso C, Bauce B, et al
     Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.
     Int J Cardiol. 2024;395:131447.
     PubMed     Abstract available
     
     
     
201. MUROKE V, Jalanko M, Haukka J, Anttila V, et al
     Long-term outcome after surgical correction of sinus venosus defect in a nationwide register-based cohort study.
     Int J Cardiol. 2024;395:131433.
     PubMed     Abstract available
     
     
     
202. KOMATSU T, Okumura M, Kida H, Takahashi J, et al
     Thin aortic arch plaque is associated with the development of atrial fibrillation for embolic stroke of undetermined source in patients with an insertable cardiac monitor.
     Int J Cardiol. 2024 Jan 9:131769. doi: 10.1016/j.ijcard.2024.131769.
     PubMed     Abstract available
     
     
     December 2023
203. HIRAM R
     The duration of atrial fibrillation might be associated with right heart disease severity.
     Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
     PubMed    
     
     
     
204. ROTTMANN FA, Abraham H, Welte T, Westermann L, et al
     Atrial fibrillation and survival on a medical intensive care unit.
     Int J Cardiol. 2023 Dec 22:131673. doi: 10.1016/j.ijcard.2023.131673.
     PubMed     Abstract available
     
     
     
205. IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
     Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
     Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
     PubMed     Abstract available
     
     
     
206. XING Y, Zhang Y, Zhao R, Shi J, et al
     Changes of left atrial morphology and function evaluated with four-dimensional automated left atrial quantification echocardiography in patients with coronary slow flow phenomenon and preserved left ventricular ejection fraction.
     Int J Cardiol. 2023;393:131351.
     PubMed     Abstract available
     
     
     
207. HU H, Yang J
     Heart failure complicated by atrial fibrillation: How to make better choices for anticoagulation?
     Int J Cardiol. 2023 Dec 6:131644. doi: 10.1016/j.ijcard.2023.131644.
     PubMed    
     
     
     
208. YAO PC, Fei ZT, Chen M, Mo BF, et al
     Incidence, impact and predictors of residual device patency after left atrial appendage closure with the LACbes device.
     Int J Cardiol. 2023 Dec 6:131640. doi: 10.1016/j.ijcard.2023.131640.
     PubMed     Abstract available
     
     
     
209. GIANNAKOULAS G, Baroutidou A
     Predicting antepartum arrhythmias in congenital heart disease: A step forward?
     Int J Cardiol. 2023;392:131287.
     PubMed    
     
     
     November 2023
210. KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
     Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
     Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
     PubMed     Abstract available
     
     
     
211. CEMIN R, Cappato R
     Lessons derived from post authorisation safety studies (ETNA-AF and XANTUS) on once daily direct oral anticoagulants for atrial fibrillation.
     Int J Cardiol. 2023 Nov 27:131618. doi: 10.1016/j.ijcard.2023.131618.
     PubMed     Abstract available
     
     
     
212. KAULING RM, Pelosi C, Cuypers JAAE, van den Bosch AE, et al
     Long term outcome after surgical ASD-closure at young age: Longitudinal follow-up up to 50?years after surgery.
     Int J Cardiol. 2023 Nov 27:131616. doi: 10.1016/j.ijcard.2023.131616.
     PubMed     Abstract available
     
     
     
213. JUNG M, Yang PS, Kim D, Sung JH, et al
     Multimorbidity in atrial fibrillation for clinical implications using the Charlson Comorbidity Index.
     Int J Cardiol. 2023 Nov 22:131605. doi: 10.1016/j.ijcard.2023.131605.
     PubMed     Abstract available
     
     
     
214. TAYAL B, Rorth R, Kristensen SL, Wissenberg M, et al
     Comparative outcomes in patients with preexisting heart failure to those without heart failure after out-of-hospital cardiac arrest: A nationwide registry study.
     Int J Cardiol. 2023 Nov 18:131595. doi: 10.1016/j.ijcard.2023.131595.
     PubMed     Abstract available
     
     
     
215. ALEXANDRINO FB, Faaborg-Andersen CC, da Silva-de Abreu A
     Anticoagulation in patients with atrial fibrillation and heart failure: More than meets the eye?
     Int J Cardiol. 2023 Nov 16:131591. doi: 10.1016/j.ijcard.2023.131591.
     PubMed    
     
     
     
216. ROSSI VA, Laptseva N, Nebunu D, Haider T, et al
     Impaired retinal micro-vascular function in patients with atrial fibrillation.
     Int J Cardiol. 2023 Nov 16:131592. doi: 10.1016/j.ijcard.2023.131592.
     PubMed     Abstract available
     
     
     
217. CEMIN R, Maggioni AP, Boriani G, Di Pasquale G, et al
     Is there a reduced confidence towards direct oral anticoagulants compared to vitamin K antagonists in patients scheduled for an elective electrical cardioversion? The results of the BLITZ-AF study.
     Int J Cardiol. 2023;391:131302.
     PubMed     Abstract available
     
     
     
218. KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
     Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
     Int J Cardiol. 2023;391:131265.
     PubMed     Abstract available
     
     
     
219. ZORZI A, D'Ascenzi F, Andreini D, Castelletti S, et al
     Interpretation and management of premature ventricular beats in athletes: An expert opinion document of the Italian Society of Sports Cardiology (SICSPORT).
     Int J Cardiol. 2023;391:131220.
     PubMed     Abstract available
     
     
     
220. XIAO X
     The mechanistic insights into new-onset atrial fibrillation induced by SARS-CoV-2 infection.
     Int J Cardiol. 2023 Nov 11:131587. doi: 10.1016/j.ijcard.2023.131587.
     PubMed    
     
     
     
221. LOSI MA, Monda E, Lombardi R, Lioncino M, et al
     Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
     PubMed     Abstract available
     
     
     
222. LI ZH, Zhong WF, Qiu CS, Yang P, et al
     Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
     Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
     PubMed     Abstract available
     
     
     
223. LINDOW T, Mokhtari A, Nystrom A, Koul S, et al
     Comparison of diagnostic accuracy of current left bundle branch block and ventricular pacing ECG criteria for detection of occlusion myocardial infarction.
     Int J Cardiol. 2023 Nov 4:131569. doi: 10.1016/j.ijcard.2023.131569.
     PubMed     Abstract available
     
     
     
224. KELLNAR A, von Falkenhausen AS, Fichtner S, Sinner M, et al
     Effects of contemporary hard- and software mapping and ablation features on acute and long-term success in premature ventricular complex ablation.
     Int J Cardiol. 2023;390:131269.
     PubMed     Abstract available
     
     
     
225. ZHU Y, Wang Y, Liu X, Wang Y, et al
     Genetically predicted osteoprotegerin levels and the risk of cardiovascular diseases: A Mendelian randomization study.
     Int J Cardiol. 2023;390:131233.
     PubMed     Abstract available
     
     
     
226. LEVENTOPOULOS G, Travlos CK, Aronis KN, Anagnostopoulou V, et al
     Safety and efficacy of left bundle branch area pacing compared with right ventricular pacing in patients with bradyarrhythmia and conduction system disorders: Systematic review and meta-analysis.
     Int J Cardiol. 2023;390:131230.
     PubMed     Abstract available
     
     
     
227. IDIAZABAL-AYESA U, Ramirez-Velez R, Sanz-de la Garza M, Izquierdo M, et al
     Electrocardiographic findings in pediatric versus young-adolescent athletes: A comparative analysis using general international criteria.
     Int J Cardiol. 2023;390:131201.
     PubMed     Abstract available
     
     
     October 2023
228. BRANDES A
     Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
     Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
     PubMed    
     
     
     
229. BICCIRE FG, Lip GYH, Pastori D
     Reply to: The C2HEST and mC2HEST scores to predict the risk of new onset atrial fibrillation after presentation with acute coronary syndrome.
     Int J Cardiol. 2023 Oct 21:131547. doi: 10.1016/j.ijcard.2023.131547.
     PubMed    
     
     
     
230. SERI A, Rabadi A, Baral N, Andi K, et al
     Prevalence of respiratory failure and use of mechanical ventilation in heart failure patients undergoing left atrial appendage occlusion device implantation.
     Int J Cardiol. 2023 Oct 21:131552. doi: 10.1016/j.ijcard.2023.131552.
     PubMed     Abstract available
     
     
     
231. GUARRACINI F, Maines M, Nappi F, Vitulano G, et al
     Daily and automatic remote monitoring of implantable cardiac monitors: A descriptive analysis of transmitted episodes.
     Int J Cardiol. 2023;389:131199.
     PubMed     Abstract available
     
     
     
232. GANDAEVA L, Sonicheva-Paterson N, McKenna WJ, Savostyanov K, et al
     Clinical features of pediatric Danon disease and the importance of early diagnosis.
     Int J Cardiol. 2023;389:131189.
     PubMed     Abstract available
     
     
     
233. ANSARI RAMANDI MM, Yarmohammadi H, Gareb B, Voors AA, et al
     Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: A systematic review and meta-analysis.
     Int J Cardiol. 2023;389:131159.
     PubMed     Abstract available
     
     
     
234. GAO P, Gao X, Xie B, Tse G, et al
     Aging and atrial fibrillation: A vicious circle.
     Int J Cardiol. 2023 Oct 15:131445. doi: 10.1016/j.ijcard.2023.131445.
     PubMed     Abstract available
     
     
     
235. MOCKEL M, Pudasaini S, Baberg HT, Levenson B, et al
     Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study.
     Int J Cardiol. 2023 Oct 10:131434. doi: 10.1016/j.ijcard.2023.131434.
     PubMed     Abstract available
     
     
     September 2023
236. YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
     Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
     Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
     PubMed     Abstract available
     
     
     
237. GENNARO N, Ferroni E, Zorzi M, Denas G, et al
     ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAIVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
     Int J Cardiol. 2023 Sep 16:131369. doi: 10.1016/j.ijcard.2023.131369.
     PubMed     Abstract available
     
     
     
238. SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
     Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
     Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
     PubMed     Abstract available
     
     
     
239. FUMAGALLI C, Zampieri M, Argiro A, Tassetti L, et al
     Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis.
     Int J Cardiol. 2023 Sep 7:131346. doi: 10.1016/j.ijcard.2023.131346.
     PubMed     Abstract available
     
     
     
240. HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
     Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
     Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
     PubMed     Abstract available
     
     
     August 2023
241. BICCIRE FG, Lip GYH, Pastori D
     Reply to: Prediction scores for new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Two sides of the same coin.
     Int J Cardiol. 2023 Aug 31:131305. doi: 10.1016/j.ijcard.2023.131305.
     PubMed    
     
     
     
242. JESSEN N, Andersen JA, Tayal B, Ostergaard L, et al
     Takotsubo syndrome and stroke risk: A nationwide register-based study.
     Int J Cardiol. 2023 Aug 22:131283. doi: 10.1016/j.ijcard.2023.131283.
     PubMed     Abstract available
     
     
     July 2023
243. PAPAPOSTOLOU S, Kearns J, Costello BT, O'Brien J, et al
     Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source.
     Int J Cardiol. 2023 Jul 25:131215. doi: 10.1016/j.ijcard.2023.131215.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.